| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/05/1992 | WO1992000074A3 Pyridopyrazine derivatives for treating substance abuse and addiction |
| 03/05/1992 | CA2090853A1 Certain cycloalkyl imidazopyrimidines, a new class of gaba brain receptor ligands |
| 03/05/1992 | CA2089770A1 Heterocyclic compounds and their preparation and use |
| 03/04/1992 | EP0473550A1 Indolonaphthyridines |
| 03/04/1992 | EP0473442A1 A substituted pyrazine and its salts, compositions containing them and their use in medicine |
| 03/04/1992 | EP0473285A1 Use of 2-(phenoxypropanolamino)ethoxyphenoxyacetic acid and its derivatives to inhibit gastrointestinal motility |
| 03/04/1992 | EP0473252A2 Use of L-deprenyl for retarding deterioration due to aging in dogs |
| 03/04/1992 | EP0180597B1 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
| 03/04/1992 | CN1059143A Pyrazolopyridine compound and process for prepn. thereof |
| 03/04/1992 | CN1059142A Thiophene derivatives |
| 03/03/1992 | US5093525 Neuroprotective agents |
| 03/03/1992 | US5093493 Anxiolytic agents, antidepressants |
| 03/03/1992 | US5093350 Dehydrocycloclausenamide, its preparation and use in treating cerebral hypoxia |
| 03/03/1992 | US5093337 Substituted derivatives of 20,21-dinoreburnamenine, their use as medicaments and the pharmaceutical compositions containing them |
| 03/03/1992 | US5093336 Treatment of cardiac failure and memory deficit |
| 03/03/1992 | US5093317 Treating disorders by application of insulin-like growth factor |
| 03/03/1992 | US5093133 Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
| 03/03/1992 | US5093129 Method for treating addiction to a drug of abuse employing an ace inhibitor |
| 03/03/1992 | CA1296736C Substituted propane-phosphonous acid compounds |
| 03/03/1992 | CA1296730C 6,7,8,9-tetrahydropyrido[1,2-a] indole derivatives |
| 03/03/1992 | CA1296724C 4-substituted 10-cyanomethylenepyrrolo [4,3-e]-benzazepines |
| 03/03/1992 | CA1296633C Controlled release bases for pharmaceuticals |
| 03/01/1992 | WO1992004338A1 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
| 03/01/1992 | WO1992004322A1 Alpha-substituted tryptophane dipeptoid derivatives |
| 03/01/1992 | CA2088996A1 Alpha-substituted tryptophane dipeptoid derivatives |
| 03/01/1992 | CA2050264A1 Substituted pyrazine and its salts, compositions containing them and their use in medicine |
| 03/01/1992 | CA2049803A1 Serotonin 5ht1a agonists |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/28/1992 | CA2049642A1 Indolonaphthyridines |
| 02/26/1992 | EP0472501A2 Codeinsalt of a substituted carbonacid, process of its preparation, its use and pharmaceutical preparations |
| 02/26/1992 | EP0472304A2 Pharmaceutical compositions containing therapeutically active organosilane derivatives and process for preparing same |
| 02/26/1992 | EP0472166A1 Tricyclic pyridone derivatives |
| 02/26/1992 | EP0471787A1 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor |
| 02/26/1992 | CN1058962A 6-substituted-hexahydrobenz(cd)indoles |
| 02/26/1992 | CN1058961A 6-substituted-tetrahydrobenz(cd)indoles |
| 02/26/1992 | CN1015627B Aryl piperazinyl-alkylene phenyl heterocyclic compounds |
| 02/26/1992 | CN1015622B Hydrocinnamic acid derivatives |
| 02/25/1992 | WO1992003426A1 Piperazinyl derivatives |
| 02/25/1992 | US5091528 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents |
| 02/25/1992 | US5091432 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use |
| 02/25/1992 | US5091429 Derivatives of 4-amino-1-trifluoromethyltetralines their preparation and their therapeutic application |
| 02/25/1992 | US5091427 Cognition activators |
| 02/25/1992 | US5091426 5-phenyl-2-furan ketones and use as antiepileptic agents |
| 02/25/1992 | US5091422 Treating inflammatory or allergic skin disease, lowering gastric acidity |
| 02/25/1992 | US5091402 Use of substituted imidazoles |
| 02/25/1992 | US5091397 1-aza-bicyclico(2.2.1)heptanes |
| 02/25/1992 | US5091393 Useful for treating schizophrenia, depression, epilepsy; vascular and respiratory system disorders |
| 02/25/1992 | CA2089768A1 Piperazinyl derivatives |
| 02/25/1992 | CA2037120A1 Pyrrolidine derivatives and nootropic agents |
| 02/25/1992 | CA1296342C Anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation |
| 02/25/1992 | CA1296335C Dichloroaniline derivatives |
| 02/24/1992 | CA2049649A1 Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions |
| 02/22/1992 | CA2048003A1 Tricyclic pyridone derivatives |
| 02/21/1992 | WO1992003138A1 Improvements in or relating to organic compounds |
| 02/21/1992 | CA2065421A1 Organic compounds |
| 02/21/1992 | CA2049401A1 Heparin binding neurotrophic factor gene sequence |
| 02/21/1992 | CA2049370A1 Human mk gene and protein sequence |
| 02/20/1992 | WO1992002620A1 Chimeric neurotrophic factors |
| 02/20/1992 | WO1992002248A1 Tachykinin agonists for treatment of alzheimer's disease |
| 02/20/1992 | CA2088990A1 Chimeric neurotrophic factors |
| 02/19/1992 | EP0471660A2 Protein C for treating pain |
| 02/19/1992 | EP0471576A1 6-substituted-tetrahydrobenz[cd]indoles |
| 02/19/1992 | EP0471569A1 6-Substituted-hexahydrobenz (CD) indoles |
| 02/19/1992 | EP0471515A1 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes |
| 02/19/1992 | EP0471298A1 Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs |
| 02/19/1992 | EP0471297A1 3-(1,2-Benzisoxazol-3-yl)-4-pyridinamines and derivatives |
| 02/19/1992 | EP0471296A1 1-(Pyridinylalkyl)-1H-indoles, indolines and related analogs |
| 02/19/1992 | EP0471009A1 Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
| 02/19/1992 | CN1058778A 吲哚衍生物 Indole derivatives |
| 02/19/1992 | CN1058716A Process for preparation of agent with active substance flupirtine to combat muscular tension and use of flupirtine for such purpose |
| 02/18/1992 | WO1992003542A1 PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID β-PROTEIN PRECURSOR |
| 02/18/1992 | US5089639 N-cycloalkylalkylamines, process for their preparation, their use as a medicament and their synthesis intermediates |
| 02/18/1992 | US5089636 Solvent extraction, drying, acidifying, precipitating |
| 02/18/1992 | US5089519 Antidepressants; antagonists for alpha-2-adrenergic receptors |
| 02/18/1992 | US5089517 Neuroprotection by indolactam v and derivatives thereof |
| 02/18/1992 | US5089507 Heterocyclic piperidinyl compounds having analgesic effect |
| 02/18/1992 | US5089506 Ethanobicyclic amine derivatives for cns disorders |
| 02/18/1992 | US5089505 1-arylethyl-3-substituted piperidines |
| 02/18/1992 | US5089472 Administering for short term memory or attention |
| 02/18/1992 | US5089276 Calcium pantothenate composite |
| 02/18/1992 | US5089267 Treating Alzheimer*s |
| 02/18/1992 | US5089265 Mixture with product of lactobacillus fermentation of rice bran; for deodorizing |
| 02/18/1992 | CA1296021C 2-(benzhydrylsulfonyl)acetamide, a process for its preparation and itstherapeutic use |
| 02/18/1992 | CA1296004C Aza-indole derivatives |
| 02/16/1992 | WO1992003134A1 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole |
| 02/16/1992 | CA2088775A1 Pharmaceutical formulations of 5- (2-chloro-1-hydroxyethyl)-4-methylthiazole |
| 02/16/1992 | CA2048846A1 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and aminothiochromanes |
| 02/14/1992 | WO1992003131A1 Use of heterocyclic amino-alcohol compounds for treatment of cns diseases |
| 02/14/1992 | CA2087449A1 Use of heterocyclic amino-alcohol compounds for treatment of cns diseases |
| 02/12/1992 | EP0470668A1 A process for preparing enantiomers of compounds having muscarinic activity |
| 02/12/1992 | EP0470317A1 Use of a derivative of 1,3,7-trimethylxanthine for the treatment of memory disorders, senile intellectual disorders and Alzheimer's disease |
| 02/12/1992 | EP0470176A1 Substituted 3-amino chromans. |
| 02/12/1992 | EP0470127A1 Pcp receptor ligands and the use thereof |
| 02/12/1992 | CN1015457B 5-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazine |
| 02/11/1992 | WO1992002224A1 Antiparkinson mao reversible inhibitor |
| 02/11/1992 | US5087628 Cognition activators |
| 02/11/1992 | US5087627 Agent for treatment of disorders of the cerebro-neural transmission system |
| 02/11/1992 | CA2067170A1 Antiparkinson mao reversible inhibitor |
| 02/11/1992 | CA1295624C Process for the manufacture of novel guanidinium aspartates |